5-[5-(3,5-dichlorophenyl)-5-methyl-4H-1,2-oxazol-3-yl]-N-[(1-hydroxy-3H-2,1-benzoxaborol-6-yl)methyl]indolizine-8-carboxamide;5-[5-(3,5-dichlorophenyl)-5-methyl-4H-1,2-oxazol-3-yl]indolizine-8-carboxylic acid;(1-hydroxy-3H-2,1-benzoxaborol-6-yl)methanamine;methane;hydrochloride

C55H51B2Cl5N6O9 — CID 159353682

IUPAC5-[5-(3,5-dichlorophenyl)-5-methyl-4H-1,2-oxazol-3-yl]-N-[(1-hydroxy-3H-2,1-benzoxaborol-6-yl)methyl]indolizine-8-carboxamide;5-[5-(3,5-dichlorophenyl)-5-methyl-4H-1,2-oxazol-3-yl]indolizine-8-carboxylic acid;(1-hydroxy-3H-2,1-benzoxaborol-6-yl)methanamine;methane;hydrochloride
SMILESC.CC1(c2cc(Cl)cc(Cl)c2)CC(c2ccc(C(=O)NCc3ccc4c(c3)B(O)OC4)c3cccn23)=NO1.CC1(c2cc(Cl)cc(Cl)c2)CC(c2ccc(C(=O)O)c3cccn23)=NO1.Cl.NCc1ccc2c(c1)B(O)OC2
InChIInChI=1S/C27H22BCl2N3O4.C19H14Cl2N2O3.C8H10BNO2.CH4.ClH/c1-27(18-10-19(29)12-20(30)11-18)13-23(32-37-27)25-7-6-21(24-3-2-8-33(24)25)26(34)31-14-16-4-5-17-15-36-28(35)22(17)9-16;1-19(11-7-12(20)9-13(21)8-11)10-15(22-26-19)17-5-4-14(18(24)25)16-3-2-6-23(16)17;10-4-6-1-2-7-5-12-9(11)8(7)3-6;;/h2-12,35H,13-15H2,1H3,(H,31,34);2-9H,10H2,1H3,(H,24,25);1-3,11H,4-5,10H2;1H4;1H
InChIKeyWRNWDDYIAHLTAL-UHFFFAOYSA-N
MW1138.93 g/mol
LogP9.84
Rot. Bonds9

About 5-[5-(3,5-dichlorophenyl)-5-methyl-4H-1,2-oxazol-3-yl]-N-[(1-hydroxy-3H-2,1-benzoxaborol-6-yl)methyl]indolizine-8-carboxamide;5-[5-(3,5-dichlorophenyl)-5-methyl-4H-1,2-oxazol-3-yl]indolizine-8-carboxylic acid;(1-hydroxy-3H-2,1-benzoxaborol-6-yl)methanamine;methane;hydrochloride

5-[5-(3,5-dichlorophenyl)-5-methyl-4H-1,2-oxazol-3-yl]-N-[(1-hydroxy-3H-2,1-benzoxaborol-6-yl)methyl]indolizine-8-carboxamide;5-[5-(3,5-dichlorophenyl)-5-methyl-4H-1,2-oxazol-3-yl]indolizine-8-carboxylic acid;(1-hydroxy-3H-2,1-benzoxaborol-6-yl)methanamine;methane;hydrochloride (PubChem CID 159353682) has the molecular formula C55H51B2Cl5N6O9 and a molecular weight of 1138.93 g/mol. Its IUPAC name is 5-[5-(3,5-dichlorophenyl)-5-methyl-4H-1,2-oxazol-3-yl]-N-[(1-hydroxy-3H-2,1-benzoxaborol-6-yl)methyl]indolizine-8-carboxamide;5-[5-(3,5-dichlorophenyl)-5-methyl-4H-1,2-oxazol-3-yl]indolizine-8-carboxylic acid;(1-hydroxy-3H-2,1-benzoxaborol-6-yl)methanamine;methane;hydrochloride.

Molecular Properties

Compound Name5-[5-(3,5-dichlorophenyl)-5-methyl-4H-1,2-oxazol-3-yl]-N-[(1-hydroxy-3H-2,1-benzoxaborol-6-yl)methyl]indolizine-8-carboxamide;5-[5-(3,5-dichlorophenyl)-5-methyl-4H-1,2-oxazol-3-yl]indolizine-8-carboxylic acid;(1-hydroxy-3H-2,1-benzoxaborol-6-yl)methanamine;methane;hydrochloride
PubChem CID159353682
Molecular FormulaC55H51B2Cl5N6O9
Molecular Weight1138.93 g/mol
Exact Mass1136.23
IUPAC Name5-[5-(3,5-dichlorophenyl)-5-methyl-4H-1,2-oxazol-3-yl]-N-[(1-hydroxy-3H-2,1-benzoxaborol-6-yl)methyl]indolizine-8-carboxamide;5-[5-(3,5-dichlorophenyl)-5-methyl-4H-1,2-oxazol-3-yl]indolizine-8-carboxylic acid;(1-hydroxy-3H-2,1-benzoxaborol-6-yl)methanamine;methane;hydrochloride
SMILESC.CC1(c2cc(Cl)cc(Cl)c2)CC(c2ccc(C(=O)NCc3ccc4c(c3)B(O)OC4)c3cccn23)=NO1.CC1(c2cc(Cl)cc(Cl)c2)CC(c2ccc(C(=O)O)c3cccn23)=NO1.Cl.NCc1ccc2c(c1)B(O)OC2
InChIInChI=1S/C27H22BCl2N3O4.C19H14Cl2N2O3.C8H10BNO2.CH4.ClH/c1-27(18-10-19(29)12-20(30)11-18)13-23(32-37-27)25-7-6-21(24-3-2-8-33(24)25)26(34)31-14-16-4-5-17-15-36-28(35)22(17)9-16;1-19(11-7-12(20)9-13(21)8-11)10-15(22-26-19)17-5-4-14(18(24)25)16-3-2-6-23(16)17;10-4-6-1-2-7-5-12-9(11)8(7)3-6;;/h2-12,35H,13-15H2,1H3,(H,31,34);2-9H,10H2,1H3,(H,24,25);1-3,11H,4-5,10H2;1H4;1H
InChIKeyWRNWDDYIAHLTAL-UHFFFAOYSA-N
XLogP9.84
TPSA203.34 Ų
H-Bond Donors5
H-Bond Acceptors13
Rotatable Bonds9
Heavy Atoms77
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001138.93
LogP ≤ 59.84
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze 5-[5-(3,5-dichlorophenyl)-5-methyl-4H-1,2-oxazol-3-yl]-N-[(1-hydroxy-3H-2,1-benzoxaborol-6-yl)methyl]indolizine-8-carboxamide;5-[5-(3,5-dichlorophenyl)-5-methyl-4H-1,2-oxazol-3-yl]indolizine-8-carboxylic acid;(1-hydroxy-3H-2,1-benzoxaborol-6-yl)methanamine;methane;hydrochloride with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-[5-(3,5-dichlorophenyl)-5-methyl-4H-1,2-oxazol-3-yl]-N-[(1-hydroxy-3H-2,1-benzoxaborol-6-yl)methyl]indolizine-8-carboxamide;5-[5-(3,5-dichlorophenyl)-5-methyl-4H-1,2-oxazol-3-yl]indolizine-8-carboxylic acid;(1-hydroxy-3H-2,1-benzoxaborol-6-yl)methanamine;methane;hydrochloride?
The IUPAC name of 5-[5-(3,5-dichlorophenyl)-5-methyl-4H-1,2-oxazol-3-yl]-N-[(1-hydroxy-3H-2,1-benzoxaborol-6-yl)methyl]indolizine-8-carboxamide;5-[5-(3,5-dichlorophenyl)-5-methyl-4H-1,2-oxazol-3-yl]indolizine-8-carboxylic acid;(1-hydroxy-3H-2,1-benzoxaborol-6-yl)methanamine;methane;hydrochloride (CID 159353682) is 5-[5-(3,5-dichlorophenyl)-5-methyl-4H-1,2-oxazol-3-yl]-N-[(1-hydroxy-3H-2,1-benzoxaborol-6-yl)methyl]indolizine-8-carboxamide;5-[5-(3,5-dichlorophenyl)-5-methyl-4H-1,2-oxazol-3-yl]indolizine-8-carboxylic acid;(1-hydroxy-3H-2,1-benzoxaborol-6-yl)methanamine;methane;hydrochloride.
What is the SMILES notation for 5-[5-(3,5-dichlorophenyl)-5-methyl-4H-1,2-oxazol-3-yl]-N-[(1-hydroxy-3H-2,1-benzoxaborol-6-yl)methyl]indolizine-8-carboxamide;5-[5-(3,5-dichlorophenyl)-5-methyl-4H-1,2-oxazol-3-yl]indolizine-8-carboxylic acid;(1-hydroxy-3H-2,1-benzoxaborol-6-yl)methanamine;methane;hydrochloride?
The canonical SMILES for 5-[5-(3,5-dichlorophenyl)-5-methyl-4H-1,2-oxazol-3-yl]-N-[(1-hydroxy-3H-2,1-benzoxaborol-6-yl)methyl]indolizine-8-carboxamide;5-[5-(3,5-dichlorophenyl)-5-methyl-4H-1,2-oxazol-3-yl]indolizine-8-carboxylic acid;(1-hydroxy-3H-2,1-benzoxaborol-6-yl)methanamine;methane;hydrochloride is C.CC1(c2cc(Cl)cc(Cl)c2)CC(c2ccc(C(=O)NCc3ccc4c(c3)B(O)OC4)c3cccn23)=NO1.CC1(c2cc(Cl)cc(Cl)c2)CC(c2ccc(C(=O)O)c3cccn23)=NO1.Cl.NCc1ccc2c(c1)B(O)OC2.
What is the InChIKey of 5-[5-(3,5-dichlorophenyl)-5-methyl-4H-1,2-oxazol-3-yl]-N-[(1-hydroxy-3H-2,1-benzoxaborol-6-yl)methyl]indolizine-8-carboxamide;5-[5-(3,5-dichlorophenyl)-5-methyl-4H-1,2-oxazol-3-yl]indolizine-8-carboxylic acid;(1-hydroxy-3H-2,1-benzoxaborol-6-yl)methanamine;methane;hydrochloride?
The InChIKey is WRNWDDYIAHLTAL-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H22BCl2N3O4.C19H14Cl2N2O3.C8H10BNO2.CH4.ClH/c1-27(18-10-19(29)12-20(30)11-18)13-23(32-37-27)25-7-6-21(24-3-2-8-33(24)25)26(34)31-14-16-4-5-17-15-36-28(35)22(17)9-16;1-19(11-7-12(20)9-13(21)8-11)10-15(22-26-19)17-5-4-14(18(24)25)16-3-2-6-23(16)17;10-4-6-1-2-7-5-12-9(11)8(7)3-6;;/h2-12,35H,13-15H2,1H3,(H,31,34);2-9H,10H2,1H3,(H,24,25);1-3,11H,4-5,10H2;1H4;1H.
What are the key properties of 5-[5-(3,5-dichlorophenyl)-5-methyl-4H-1,2-oxazol-3-yl]-N-[(1-hydroxy-3H-2,1-benzoxaborol-6-yl)methyl]indolizine-8-carboxamide;5-[5-(3,5-dichlorophenyl)-5-methyl-4H-1,2-oxazol-3-yl]indolizine-8-carboxylic acid;(1-hydroxy-3H-2,1-benzoxaborol-6-yl)methanamine;methane;hydrochloride?
5-[5-(3,5-dichlorophenyl)-5-methyl-4H-1,2-oxazol-3-yl]-N-[(1-hydroxy-3H-2,1-benzoxaborol-6-yl)methyl]indolizine-8-carboxamide;5-[5-(3,5-dichlorophenyl)-5-methyl-4H-1,2-oxazol-3-yl]indolizine-8-carboxylic acid;(1-hydroxy-3H-2,1-benzoxaborol-6-yl)methanamine;methane;hydrochloride has a molecular weight of 1138.93 g/mol, XLogP of 9.84, 9 rotatable bonds, 5 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[5-(3,5-dichlorophenyl)-5-methyl-4H-1,2-oxazol-3-yl]-N-[(1-hydroxy-3H-2,1-benzoxaborol-6-yl)methyl]indolizine-8-carboxamide;5-[5-(3,5-dichlorophenyl)-5-methyl-4H-1,2-oxazol-3-yl]indolizine-8-carboxylic acid;(1-hydroxy-3H-2,1-benzoxaborol-6-yl)methanamine;methane;hydrochloride is sourced from PubChem (CID 159353682), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).